The document details the financial results for various companies in Q1 FY13, including significant revenue growth for Cummins India (21.8%), Madras Cement (29.56%), and Federal Bank (23.46%). Notably, Glenmark Pharma experienced a decline in net profit, while several companies reported growth in sales but varying levels of net profit. The report emphasizes the importance of disclosures and clarifies that it is not for public distribution.

1. Results Tracker Friday, 03 Aug 2012
make more, for sure.
Q1FY13
Results to be Declared on Friday, 3rd August 2012
COMPANIES NAME
Abbott India DCM Fin Serv KCP Sugar NRB Bearings Sterling Grnty
ABC Bearings Dynamatic Tech KDDL Panoramic Univ Sun TV Network
ACI Infocom Galaxy Agri Kesar Petro PCS Technology Svam Software
AJEL Graphite India Khaitan Chem Peninsula Land Tantia Constr
Ashutosh Paper Gujarat PolyAVX Mafatlal Inds Pratiksha Chem Tata Invest
Asian Hotels (West) Gujarat State Fin Mahaveer Infoway Pulsar Intl Timex Group
Associated Fin ICRA Mahindra Ugine Punctual Trad TV Today
B2B Software India Nippon Manali Petro Raj Packaging United Bank
Balmer Lawr Inv Indsil Hydro Marico Redex Protech Vulcan Engr
BGR Energy James Hotels Master Chem Sahara One Zen Tech
Centum Elect Jet Air India Microsec Fin Serv Shantivijay Jew
City Union Bank JMC Projects MM Forgings Shirpur Gold
Commercial Engineers Jolly Plast Moser Baer Sicagen India
Cubical Fin Kalyanpur Cem Nilkamal SKS Microfinance
Results Announced on 2nd Aug 2012 (Rs Million)
Cummins India
Quarter ended Year to Date Year ended
201206 201106 % Var 201206 201106 % Var 201203 201103 % Var
Sales 12587.5 10334.9 21.8 12587.5 10334.9 21.8 41172.2 40425.3 1.85
Other Income 384.9 283.1 35.96 384.9 283.1 35.96 1233.3 803.7 53.45
PBIDT 2709.8 2022.2 34 2709.8 2022.2 34 8205.8 8437.6 -2.75
Interest 13.5 10.8 25 13.5 10.8 25 54.1 47.5 13.89
PBDT 2696.3 2525.8 6.75 2696.3 2525.8 6.75 8666.1 8390.1 3.29
Depreciation 113.9 93.5 21.82 113.9 93.5 21.82 419.8 366.4 14.57
PBT 2582.4 2432.3 6.17 2582.4 2432.3 6.17 8246.3 8023.7 2.77
TAX 776.9 660.6 17.61 776.9 660.6 17.61 2333.6 2113.8 10.4
Deferred Tax 0 0 0 0 0 0 0 0 0
PAT 1805.5 1771.7 1.91 1805.5 1771.7 1.91 5912.7 5909.9 0.05
Equity 554.4 396 40 554.4 396 40 554.4 396 40
PBIDTM(%) 21.53 19.57 10.02 21.53 19.57 10.02 19.93 20.87 -4.51
The company witnessed a 21.80% growth in the revenue at Rs. 12587.50 millions for the quarter ended June 2012 as compared to Rs.
10334.90 millions during the year-ago period.Profit for the quarter ended June 2012 grew by 1.91% to Rs. 1805.50 millions from Rs.
771.70 millions.OP of the company witnessed a marginal growth to 2709.80 millions from 2022.20 millions in the same quarter last year.
Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only
Mansukh Securities and Finance Ltd SEBI Regn No. BSE: INB010985834 / NSE: INB230781431
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002 PMS Regn No. INP000002387
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com

2. Results Tracker Q1FY13
make more, for sure.
Madras Cement
Quarter ended Year to Date Year ended
201206 201106 % Var 201206 201106 % Var 201203 201103 % Var
Sales 9952.7 7682.1 29.56 9952.7 7682.1 29.56 32782 26360.4 24.36
Other Income 17.7 18 -1.67 17.7 18 -1.67 95.8 86.7 10.5
PBIDT 3144.7 2501.8 25.7 3144.7 2501.8 25.7 9698.7 6572.4 47.57
Interest 542.6 476 13.99 542.6 476 13.99 1584.5 1392.8 13.76
PBDT 2602.1 2025.8 28.45 2602.1 2025.8 28.45 8114.2 5179.6 56.66
Depreciation 781.2 641.5 21.78 781.2 641.5 21.78 2539 2207.7 15.01
PBT 1820.9 1384.3 31.54 1820.9 1384.3 31.54 5575.2 2971.9 87.6
TAX 590.8 401.3 47.22 590.8 401.3 47.22 1723.1 862.8 99.71
Deferred Tax 149.5 172.2 -13.18 149.5 172.2 -13.18 601.8 39 1443.08
PAT 1230.1 983 25.14 1230.1 983 25.14 3852.1 2109.1 82.64
Equity 238 238 0 238 238 0 238 238 0
PBIDTM(%) 31.6 32.57 -2.98 31.6 32.57 -2.98 29.59 24.93 18.66
The Sales for the quarter ended June 2012 of Rs. 9952.70 millions rose by 29.56% from Rs. 7682.10 millions.Net Profit recorded in the
quarter ended June 2012 rise to 25.14% to Rs. 1230.10 millions compared to R. 983.00 millions in corresponding previous quarter.OP of
the company witnessed a marginal growth to 3144.70 millions from 2501.80 millions in the same quarter last year.
Glenmark Pharma
Quarter ended Year to Date Year ended
201206 201106 % Var 201206 201106 % Var 201203 201103 % Var
Sales 3924.91 3270.88 20 3924.91 3270.88 20 15646.65 11629.39 34.54
Other Income 122.06 36.9 230.79 122.06 36.9 230.79 551.04 717.52 -23.2
PBIDT 717.74 1093.62 -34.37 717.74 1093.62 -34.37 3660.79 3575.31 2.39
Interest 106.95 129.54 -17.44 106.95 129.54 -17.44 608.69 857.5 -29.02
PBDT 610.79 964.08 -36.65 610.79 964.08 -36.65 3052.1 2717.81 12.3
Depreciation 0 49.67 0 0 49.67 0 211.13 209.88 0.6
PBT 610.79 914.41 -33.2 610.79 914.41 -33.2 2840.97 2507.93 13.28
TAX 62.54 189.76 -67.04 62.54 189.76 -67.04 187.98 386.15 -51.32
Deferred Tax 0 0 0 0 0 0 0 0 0
PAT 548.25 724.65 -24.34 548.25 724.65 -24.34 2652.99 2121.78 25.04
Equity 270.62 270.33 0.11 270.62 270.33 0.11 270.53 270.27 0.1
PBIDTM(%) 18.29 33.44 -45.31 18.29 33.44 -45.31 23.4 30.74 -23.9
The Revenue for the quarter ended June 2012 of Rs. 3924.91 millions grew by 20.00 % from Rs. 3270.88 millions.The Company's Net
profit for the June 2012 quarter have declined marginally to Rs. 548.25 millions as against Rs. 724.65 millions reported during the
corresponding quarter ended.Operating Profit reported a sharp decline to 717.74 millions from 1093.62 millions in the corresponding
previous quarter.
Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only
Mansukh Securities and Finance Ltd SEBI Regn No. BSE: INB010985834 / NSE: INB230781431
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002 PMS Regn No. INP000002387
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com

3. Results Tracker Q1FY13
make more, for sure.
Federal Bank
Quarter ended Year to Date Year ended
201206 201106 % Var 201206 201106 % Var 201203 201103 % Var
Interest Earned 15367.1 12447.1 23.46 15367.1 12447.1 23.46 55583.9 40520.3 37.18
Other Income 1243.3 1169 6.36 1243.3 1169 6.36 5323.4 5168.1 3
Interest Expended 10450.7 7849.6 33.14 10450.7 7849.6 33.14 36049.9 23054.5 56.37
Operating Expenses 2694.6 2694.6 21.05 2694.6 2226 21.05 9792.7 8361.4 17.12
Operating Profit 0 0 0 0 0 0 11695 0 0
Prov.& Contigencies 627.8 1340.2 -53.16 627.8 1340.2 -53.16 3369.7 5254.4 -35.87
Tax 933.8 738.7 26.41 933.8 738.7 26.41 3927.1 3147.3 24.78
PAT 1903.5 1461.6 30.23 1903.5 1461.6 30.23 7767.9 5870.8 32.31
Equity 1710.5 1710.5 0 1710.5 1710.5 0 1710.5 1710.5 0
OPM 22.55 28.44 -20.73 22.55 28.44 -20.73 27.1 35.22 -23.05
The Revenue for the quarter ended June 2012 of Rs. 15367.10 millions grew by 23.46 % from Rs. 12447.10 millions.Good Net Profit
growth of 30.23% reported above the corresponding previous quarter figure of Rs. 1461.60 millions to Rs. 1903.50 millioins.
Hotel Leela Venture
Quarter ended Year to Date Year ended
201206 201106 % Var 201206 201106 % Var 201203 201103 % Var
Sales 1380 1120.3 23.18 1380 1120.3 23.18 5710.9 4640.4 23.07
Other Income 32.5 0.6 5316.67 32.5 0.6 5316.67 165.7 269.7 -38.56
PBIDT 192.3 173.5 10.84 192.3 173.5 10.84 351.8 1568.5 -77.57
Interest 890.7 370.7 140.28 890.7 370.7 140.28 3212.5 560.8 472.84
PBDT -698.4 -178.2 291.92 -698.4 -178.2 291.92 1315.9 1193.1 10.29
Depreciation 320.4 181.7 76.33 320.4 181.7 76.33 1022.4 629.6 62.39
PBT -1018.8 -359.9 183.08 -1018.8 -359.9 183.08 293.5 563.5 -47.91
TAX 0 -95 0 0 -95 0 107.2 185.1 -42.09
Deferred Tax 0 0 0 0 0 0 -23.3 152.4 -115.29
PAT -1018.8 -264.9 284.6 -1018.8 -264.9 284.6 186.3 378.4 -50.77
Equity 775.6 775.6 0 775.6 775.6 0 775.6 775.6 0
PBIDTM(%) 13.93 15.49 -10.02 13.93 15.49 -10.02 6.16 33.8 -81.78
A fair growth of 23.18% in the revenue at Rs. 1380.00 millions was reported in the June 2012 quarter as compared to Rs. 1120.30 millions
during year-ago period.The Net Loss for the quarter ended June 2012 is Rs. -1018.80 millions as compared to Net Loss of Rs. -264.90
millions of corresponding quarter ended June 2011Operating profit for the quarter ended June 2012 rose to 192.30 millions as compared
to 173.50 millions of corresponding quarter ended June 2011.
Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only
Mansukh Securities and Finance Ltd SEBI Regn No. BSE: INB010985834 / NSE: INB230781431
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002 PMS Regn No. INP000002387
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com

4. Results Tracker Q1FY13
make more, for sure.
Data Source : ACE Equity
NAME DESIGNATION E-MAIL
Varun Gupta Head - Research varungupta@moneysukh.com
Pashupati Nath Jha Research Analyst pashupatinathjha@moneysukh.com
Vikram Singh Research Analyst vikram_research@moneysukh.com
This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you.
Mansukh Securities and Finance Ltd (hereinafter referred as MSFL) is not soliciting any action based on it. This report is not for public distribution and
has been furnished to you solely for your information and should not be reproduced or redistributed to any person in any form.
The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete. MSFL or any of its affiliates or
employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information
contained in this report. MSFL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding
any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-
infringement. The recipients of this report should rely on their own investigations.
MSFL and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. This
information is subject to change without any prior notice. MSFL reserves the right to make modifications and alterations to this statement as may be
required from time to time. Nevertheless, MSFL is committed to providing independent and transparent recommendations to its clients, and would be
happy to provide information in response to specific client queries.
Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only
Mansukh Securities and Finance Ltd SEBI Regn No. BSE: INB010985834 / NSE: INB230781431
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002 PMS Regn No. INP000002387
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com